Ilaria C.
- Country
- Italy
- Department
- U.O. Reumatologia e Immunologia Clinica
Research Overview
- Phase 2 Randomized Double‑Blind Placebo‑Controlled Trial of Subcutaneous Daxdilimab (with background prednisone) in Adults with Dermatomyositis or Anti‑Synthetase Myositis
- Efficacy and Safety Evaluation of Nerandomilast in Systemic Autoimmune Rheumatic Diseases-Associated Interstitial Lung Diseases: A Randomized, Double-Blind, Placebo-Controlled Trial
- A randomized, double-blind, placebo-controlled, multi-center study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of orally administered GLPG3667 once daily for 24 weeks in adult subjects with dermatomyositis
Data & Insights
Has run more than one trial at 12 of 73 partner sites.
Specializations
Inflammatory Muscle Disorders
The investigator specializes in studying idiopathic inflammatory myopathies, with particular emphasis on two significant conditions: dermatomyositis and polymyositis. Their research focuses on understanding and treating these rare autoimmune muscle disorders that cause progressive muscle weakness.
- Dermatomyositis Management
- Polymyositis Treatment
- Muscle Symptom Assessment
The investigator's work centers on evaluating innovative therapeutic approaches for patients with active forms of these conditions.
Autoimmune Disorders
Their expertise extends to the broader field of autoimmune disorders, particularly those affecting muscle tissue. The investigator's research encompasses comprehensive evaluation of novel therapeutic agents targeting specific pathways in autoimmune muscle diseases.
- Inflammatory Disease Mechanisms
- Autoimmune Response Patterns
- Clinical Disease Assessment
Their work aims to advance understanding of treatment responses in autoimmune muscle conditions.
Clinical Therapeutics
The investigator's research includes evaluation of therapeutic interventions for muscle-related inflammatory conditions. Their work involves assessing the effectiveness of treatments in reducing muscle symptoms and improving patient outcomes.
- Treatment Efficacy Assessment
- Safety Profile Evaluation
- Therapeutic Response Monitoring
Their research contributes to developing effective treatment strategies for inflammatory muscle disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.